Back to Test Catalogue

Mold IgE Panel + Total IgE, Serum

Test ID: METEBT
Orderable by Ontario ND

Test

Method

Immunoassay

Method Description

US BioTek runs all IgE panels on a sophisticated FDA-approved immunoassay analyzer that utilizes enzyme-amplified chemiluminescence technology. Chemiluminescence provides lower detection limits than conventional ELISA, making it particularly suitable for IgE detection, which can be hard to detect due to its short half-life compared to other immunoglobulins.

Source: https://www.usbiotek.com/tests/; Accessed 28-May-2019.

Platform

ELISA

Report Includes

Alternaria tenuis; Aspergillus fumigatus ; Candida albicans; Cladosporium herbarum; Curvularia lunata; Epicoccum purpurascens; Fusarium moniliforme; Helminthosporium halodes; Mucor racemosus; Penicillium notatum; Phoma betae; Pityrosporum orbiculare; Rhizopus nigricans; Stemphylium botryosum; Trichoderma viride; Total IgE

Specimens

Serum

Clinical Utility

Airborne exposure to molds has been known to cause allergic symptoms in sensitive individuals, including coughing, sneezing, asthma, and skin rashes. Our Mold Panel tests IgE antibody response to 15 common molds.

Our Total IgE test is useful on its own or in combination with an IgG, IgG4, or IgGA antibody assessment as an overall indicator of IgE levels. Elevated levels of the antibody has been tied to allergic response.

Source: https://www.usbiotek.com/tests/; Accessed 28-May-2019.

Test Location

US Biotek, WA, USA

Test Version

30-Sep-2019

Specimen

Specimens

Serum

Sample Volume

1 mL

Additional Information

A specimen collection kit is available. To order a kit online, please register or login. For assistance or more information, please click here to send us an email or call 416-422-3000 x 300.

For additional information refer to the US Biotek website 15 Mold IgE Panel and Total IgE

Test Version

30-Sep-2019

Performance / Interpretation

Method

Immunoassay

Method Description

US BioTek runs all IgE panels on a sophisticated FDA-approved immunoassay analyzer that utilizes enzyme-amplified chemiluminescence technology. Chemiluminescence provides lower detection limits than conventional ELISA, making it particularly suitable for IgE detection, which can be hard to detect due to its short half-life compared to other immunoglobulins.

Source: https://www.usbiotek.com/tests/; Accessed 28-May-2019.

Platform

ELISA

Turnaround Time

10 days

Sample Reports

Test Location

US Biotek, WA, USA

Test Version

30-Sep-2019

Interface / Setup

Sample Reports

Test Version

30-Sep-2019